RepliCel Life Sciences Inc. is leading a revolution in the development of products for sports medicine and aesthetics.
We are a regenerative medicine company developing innovative, clinical-stage technologies for unparalleled skin rejuvenation, tendon regeneration, and hair regrowth.
RepliCel is currently involved in three clinical development programs: RCT-01 for treatment of Achilles tendinosis, RCS-01 for skin rejuvenation, and RCH-01 for treatment of Androgenic Alopecia.
In Asia, RCH-01 is the subject of a co-development partnership with cosmetics and skincare giant Shiseido Company, Limited. Shiseido is currently funding a clinical study for the treatment of male and female pattern baldness (androgenic alopecia) in Japan with data anticipated in late 2018.
RepliCel's nearest-term commercial asset is its next-generation dermal injector, RCI-02 which represents a medical device bringing unparalleled precision and consistency to dermal injections including shallow, even dispersion of dermal fillers for fine wrinkles. RCI-02 also promises to obviate the need for local anesthetic injections due to its patented skin-numbing element embedded in the device.
Company Details
- Employees
- 4
- Founded
- -
- Address
- Suite 900, 570 Granville St,canada
- Phone
- 604-248-8730
- in****@****cel.com
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://www.replicel.com/
- Keywords
- Hair Rejuvenation, Tendon Repair, Androgenetic Alopecia, Skin Rejuvenation, Tendinosis, Dermal Injector, biotechnology, regenerative medicine, cell therapy, tendinopathy, medical devices.
- HQ
- Vancouver, British Columbia
Replicel Life Sciences Inc. Questions
Replicel Life Sciences Inc.'s helpline number is 604-248-8730
Replicel Life Sciences Inc.'s website is http://www.replicel.com/
Replicel Life Sciences Inc.'s LinkedIn profile is https://ca.linkedin.com/company/replicel-life-sciences-inc-
Replicel Life Sciences Inc. has
4 employees.
View email and phone details for 4
employees at Replicel Life Sciences Inc..
Replicel Life Sciences Inc.'s industry is
Biotechnology Research
Replicel Life Sciences Inc.'s top competitors are
Virogin Biotech,
Lexaria Bioscience,
Novateur Ventures Inc.,
Pascal Biosciences Inc.,
Pan-Biome Pharmaceuticals, Inc,
Stemson Therapeutics,
Medicenna Therapeutics Corp.,
Me Therapeutics,
Viva Pharmaceutical Inc. Richmond,
Wex Pharmaceuticals Inc..
Replicel Life Sciences Inc.'s support email address is info@replicel.com
Replicel Life Sciences Inc.'s categories are Biotechnology Research
Replicel Life Sciences Inc.'s founding year is 2010
